1. Home
  2. APLT vs ESP Comparison

APLT vs ESP Comparison

Compare APLT & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • ESP
  • Stock Information
  • Founded
  • APLT 2016
  • ESP 1928
  • Country
  • APLT United States
  • ESP United States
  • Employees
  • APLT N/A
  • ESP N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • APLT Health Care
  • ESP Technology
  • Exchange
  • APLT Nasdaq
  • ESP Nasdaq
  • Market Cap
  • APLT 178.6M
  • ESP 148.8M
  • IPO Year
  • APLT 2019
  • ESP N/A
  • Fundamental
  • Price
  • APLT $1.05
  • ESP $38.69
  • Analyst Decision
  • APLT Buy
  • ESP
  • Analyst Count
  • APLT 5
  • ESP 0
  • Target Price
  • APLT $4.13
  • ESP N/A
  • AVG Volume (30 Days)
  • APLT 11.8M
  • ESP 45.4K
  • Earning Date
  • APLT 11-06-2025
  • ESP 11-12-2025
  • Dividend Yield
  • APLT N/A
  • ESP 2.59%
  • EPS Growth
  • APLT N/A
  • ESP 31.88
  • EPS
  • APLT N/A
  • ESP 3.02
  • Revenue
  • APLT $121,000.00
  • ESP $43,950,872.00
  • Revenue This Year
  • APLT N/A
  • ESP N/A
  • Revenue Next Year
  • APLT $5,931.24
  • ESP N/A
  • P/E Ratio
  • APLT N/A
  • ESP $12.79
  • Revenue Growth
  • APLT N/A
  • ESP 13.46
  • 52 Week Low
  • APLT $0.30
  • ESP $24.85
  • 52 Week High
  • APLT $10.62
  • ESP $55.00
  • Technical
  • Relative Strength Index (RSI)
  • APLT 66.45
  • ESP N/A
  • Support Level
  • APLT $0.56
  • ESP N/A
  • Resistance Level
  • APLT $1.32
  • ESP N/A
  • Average True Range (ATR)
  • APLT 0.17
  • ESP 0.00
  • MACD
  • APLT 0.05
  • ESP 0.00
  • Stochastic Oscillator
  • APLT 73.60
  • ESP 0.00

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: